Injectable Drug Delivery Resources
-
2R Vials And Deep Cold Storage - Determining Mechanical & CCI Performance
8/27/2024
Review the implications of this study on the storage of sensitive molecules that require deep-cold storage and learn how 2R Fina glass vials are poised to enhance cold storage practices.
-
The 10 Most Frequently Asked Questions On Glass: Part 2
2/20/2024
Read the second part of this series on the most common questions encountered by an expert focused in scientific affairs and technical solutions for glass.
-
Early Decisions To De-Risk The Transition To Combination Products
The injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?
-
Component Technologies For Cartridge Delivery Applications
Current component technologies for cartridge-based drug delivery pose challenges. In order to address these challenges, the next generation of cartridge components are evolving.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
2/20/2024
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Switching From Vials To PFS And Intravenous To Subcutaneous Formulations
7/25/2023
Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.
-
Improve Speed To Market By Mitigating Vial And Stopper Incompatibility
10/1/2024
These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.
-
Key Financial Considerations For Phase II Clinical Injectable Drug Manufacturing
9/9/2022
This article highlights the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.
-
How To Ensure Correct Component Selection When Outsourcing To A CMO
3/22/2023
A CMO-recommended lyophilization stopper was contributing to several operational inefficiencies, including sticking and interlocking of stoppers during filling operations. Requalification work was required to make a change.
-
Low Temperature Storage Containment For Vial And Syringe Systems
6/20/2025
With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.